Victoza, an explanation from Viggo Birch, MD Novo Nordisk Europe
From a talk given at the UK launch of the new Type 2 treatment given by Viggo Birch, vice president and managing director, Novo Nordisk
From a talk given at the UK launch of the new Type 2 treatment given by Viggo Birch, vice president and managing director, Novo Nordisk
Survey finds increased need for more medicines like Byetta and Januvia Initially reported in July 2009, a survey, “A Clinician and Payer Perspective on Changing
From a talk given by Professor Anthony Barnett (Professor of Medicine and Honorary Consultant Physician at the University of Birmingham and Heart Of England NHS